(6-(三氟甲基)嘧啶-4-基)甲醇 | 1356111-18-6

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二嗪类
• 中文名称: (6-(三氟甲基)嘧啶-4-基)甲醇
• 英文名称: (6-(Trifluoromethyl)pyrimidin-4-yl)methanol
• 英文别名: [6-(trifluoromethyl)pyrimidin-4-yl]methanol
• CAS: 1356111-18-6
• 化学式: C₆H₅F₃N₂O
• 分子量: 178.11
• InChiKey: XLEZWHHCIPCFBE-UHFFFAOYSA-N

物化性质

• 沸点：
  231.1±35.0 °C(Predicted)
• 密度：
  1.445±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  0.3
• 重原子数：
  12
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  46
• 氢给体数：
  1
• 氢受体数：
  6

文献信息

• Tetrahydronaphthyridine derivatives as mGluR2-negative allosteric modulators, compositions, and their use
  申请人：Merck Sharp & Dohme Corp.

  公开号：US10072003B2

  公开（公告）日：2018-09-11

  The present invention provides quinoline carboxamide and quinoline carbonitrile compounds of formula (I) or a pharmaceutically acceptable salt thereof, wherein R1, R2, L, X1, X2, and X3, are as defined herein. The compounds of the invention, and pharmaceutically acceptable salts thereof, and pharmaceutical compositions comprising them, are useful as non-competitive mGluR2 antagonists, or mGluR2 negative allosteric modulators (NAMs), and may be useful in methods of treating a person in need thereof for diseases or disorders in which the mGluR2-NAM receptor plays a causative role, such as Alzheimer's disease, cognitive impairment, schizophrenia and other mood disorders, pain disorders and sleep disorders.

  本发明提供了式(I)的喹啉甲酰胺和喹啉甲腈化合物或其药学上可接受的盐，其中R1、R2、L、X1、X2和X3如本文所定义。本发明的化合物及其药学上可接受的盐，以及包含它们的药物组合物可作为非竞争性 mGluR2 拮抗剂或 mGluR2 负异位调节剂 (NAM)，并可用于治疗有需要的人的疾病或失调的方法，在这些疾病或失调中，mGluR2-NAM 受体起致病作用，如阿尔茨海默病、认知障碍、精神分裂症和其他情绪障碍、疼痛障碍和睡眠障碍。
• TETRAHYDRONAPHTHYRIDINE DERIVATIVES AS mGluR2-NEGATIVE ALLOSTERIC MODULATORS, COMPOSITIONS, AND THEIR USE
  申请人：Merck Sharp & Dohme Corp.

  公开号：EP3185865A1

  公开（公告）日：2017-07-05
• TETRAHYDRONAPTHTYRIDINE DERIVATIVES AS MGLUR2 NEGATIVE ALLOSTERIC MODULATORS, COMPOSITIONS, AND THEIR USE.
  申请人：Merck Sharp & Dohme Corp.

  公开号：EP3185865B1

  公开（公告）日：2020-07-15
• [EN] TETRAHYDRONAPHTHYRIDINE DERIVATIVES AS mGluR2-NEGATIVE ALLOSTERIC MODULATORS, COMPOSITIONS, AND THEIR USE<br/>[FR] DERIVES DE TETRAHYDRONAPHTYRIDINE EN TANT QUE MODULATEURS ALLOSTERIQUES NEGATIFS DE MGLUR2, COMPOSITIONS ET UTILISATION DE CEUX-CI
  申请人：MERCK SHARP & DOHME

  公开号：WO2016032921A1

  公开（公告）日：2016-03-03

  The present invention provides quinoline carboxamide and quinoline carbonitrile compounds of formula (I) or a pharmaceutically acceptable salt thereof, wherein R1, R2, L, X1, X2, and X3, are as defined herein. The compounds of the invention, and pharmaceutically acceptable salts thereof, and pharmaceutical compositions comprising them, are useful as non-competitive mGluR2 antagonists, or mGluR2 negative allosteric modulators (NAMs), and may be useful in methods of treating a person in need thereof for diseases or disorders in which the mGluR2-NAM receptor plays a causative role, such as Alzheimer's disease, cognitive impairment, schizophrenia and other mood disorders, pain disorders and sleep disorders.